Table of Contents
Refractec ViewPoint™ CK System for the Treatment of Spherical Hyperopia
Questions for Panel Consideration
Question for Panel Consideration
Induced Increase in Cylinder Magnitude (% of eyes)
Induced Change in Vector Cylinder Magnitude (% of eyes)
Induced Absolute Axis Shift (% of all treated eyes)
Post-op Cylinder Magnitude (% of eyes) Note: all eyes had baseline cylinder magnitude 0.75D or less
Effect of Induced Cylinder on Uncorrected Visual Acuity (% of eyes at month 12)
Question for Panel Consideration
Question for Panel Consideration
Stability of MRSE 12-month consistent cohort (n=186)
Stability of MRSE cohort with 2 consecutive visits
Accuracy of MRSE
Question for Panel Consideration
Visual Symptoms with ?5% increase over baseline (% eyes with moderate to severe symptoms)
Question for Panel Consideration
Requested Indication for Use
Question for Panel Consideration
Questions for Panel Consideration
Question for Panel Consideration
Question for Panel Consideration
Question for Panel Consideration
Question for Panel Consideration
Question for Panel Consideration
Question for Panel Consideration
|